These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 24089413)

  • 1. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I.
    Worcester EM; Evan AP; Coe FL; Lingeman JE; Krambeck A; Sommers A; Phillips CL; Milliner D
    Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1574-84. PubMed ID: 24089413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene.
    Li Y; Zheng R; Xu G; Huang Y; Li Y; Li D; Geng H
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F475-F484. PubMed ID: 33491567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
    Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
    Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thresholds of serum calcium oxalate supersaturation in relation to renal function in patients with or without primary hyperoxaluria.
    Marangella M; Cosseddu D; Petrarulo M; Vitale C; Linari F
    Nephrol Dial Transplant; 1993; 8(12):1333-7. PubMed ID: 8159301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria.
    Wang X; Bhutani G; Vaughan LE; Enders FT; Haskic Z; Milliner D; Lieske JC;
    BMC Nephrol; 2020 Apr; 21(1):133. PubMed ID: 32293313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological correlates of two unique renal tubule lesions in rats with intestinal resection.
    Worcester E; Evan A; Bledsoe S; Lyon M; Chuang M; Orvieto M; Gerber G; Coe F
    Am J Physiol Renal Physiol; 2006 Nov; 291(5):F1061-9. PubMed ID: 17028259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.
    Michael M; Groothoff JW; Shasha-Lavsky H; Lieske JC; Frishberg Y; Simkova E; Sellier-Leclerc AL; Devresse A; Guebre-Egziabher F; Bakkaloglu SA; Mourani C; Saqan R; Singer R; Willey R; Habtemariam B; Gansner JM; Bhan I; McGregor T; Magen D
    Am J Kidney Dis; 2023 Feb; 81(2):145-155.e1. PubMed ID: 35843439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting kidney inflammation as a new therapy for primary hyperoxaluria?
    Martin-Higueras C; Ludwig-Portugall I; Hoppe B; Kurts C
    Nephrol Dial Transplant; 2019 Jun; 34(6):908-914. PubMed ID: 30169827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of assessment of serum calcium oxalate saturation in the hyperoxaluria syndromes.
    Marangella M; Vitale C; Petrarulo M; Linari F
    Nephrol Dial Transplant; 1995; 10 Suppl 8():11-3. PubMed ID: 8592617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium oxalate deposition in renal allografts: morphologic spectrum and clinical implications.
    Truong LD; Yakupoglu U; Feig D; Hicks J; Cartwight J; Sheikh-Hamad D; Suki WN
    Am J Transplant; 2004 Aug; 4(8):1338-44. PubMed ID: 15268737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium oxalate saturation in dialysis patients with and without primary hyperoxaluria.
    Ogawa Y; Machida N; Ogawa T; Oda M; Hokama S; Chinen Y; Uchida A; Morozumi M; Sugaya K; Motoyoshi Y; Hattori M
    Urol Res; 2006 Feb; 34(1):12-6. PubMed ID: 16432691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary calcium oxalate supersaturation beyond nephrolithiasis. Relationship with tubulointerstitial damage].
    Toblli JE; Angerosa M; Stella I; Ferder L; Inserra F
    Medicina (B Aires); 2003; 63(2):97-104. PubMed ID: 12793076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral native nephrectomy reduces systemic oxalate level after combined liver-kidney transplant: A case report.
    Villani V; Gupta N; Elias N; Vagefi PA; Markmann JF; Paul E; Traum AZ; Yeh H
    Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28261895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium oxalate crystal deposition in the kidney: identification, causes and consequences.
    Geraghty R; Wood K; Sayer JA
    Urolithiasis; 2020 Oct; 48(5):377-384. PubMed ID: 32719990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure.
    Marangella M; Vitale C; Petrarulo M; Tricerri A; Cerelli E; Cadario A; Barbos MP; Linari F
    Kidney Int; 1995 Jul; 48(1):182-7. PubMed ID: 7564076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
    Robertson WG
    Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hyperoxaluria: clinical course, diagnosis, and treatment after kidney failure.
    Raju DL; Cantarovich M; Brisson ML; Tchervenkov J; Lipman ML
    Am J Kidney Dis; 2008 Jan; 51(1):e1-5. PubMed ID: 18155525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttransplant recurrence of calcium oxalate crystals in patients with primary hyperoxaluria: Incidence, risk factors, and effect on renal allograft function.
    Cornell LD; Amer H; Viehman JK; Mehta RA; Lieske JC; Lorenz EC; Heimbach JK; Stegall MD; Milliner DS;
    Am J Transplant; 2022 Jan; 22(1):85-95. PubMed ID: 34174139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.